Skip to main content
. 2014 Feb 6;110(6):1645–1654. doi: 10.1038/bjc.2014.48

Figure 4.

Figure 4

Effect of miR-1260b knockdown on prostate cancer cells (PC-3, DU-145). Two prostate cancer cell lines (PC-3 and DU-145) were transiently transfected with either miR-1260b inhibitor or miR-negative control (miR-NC inhibitor). (A) Relative miR-1260b expression (miR-NC inhibitor or miR-1260b inhibitor transfected PC cells), (B) cell viability assay (miR-NC inhibitor or miR-1260b inhibitor transfected PC cells), (C) invasion assay, (D) wound healing assay (16–17 h). (E) Apoptosis assay, (F) cell cycle analysis, (G) TCF reporter assay. Error bars represent ±s.d.

HHS Vulnerability Disclosure